Image

Family Involvement Hospital Ethnography

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about the role of family members in caring for hospitalized older adults with cognitive impairment. The main questions it aims to answer

are
  1. What features of the healthcare system facilitate or hinder family involvement in care from the perspective of patients, families, and healthcare workers?
  2. How do hospital leaders understand the facilitators and barriers to family involvement?

Data collection will occur via semi-structure interviews, direct observation, and artifact analysis.

Description

The investigators will use three complementary ethnographic approaches to achieve the study aims: direct observation (Aim 1); interviews with key informants (Aims 1 and 2); and analysis of artifacts such as policy documents related to visitation, care of cognitively impaired older adults, and family-centered care in the hospital (Aim 2).

AIM 1: To identify facilitators and barriers to family member involvement in the care of hospitalized older adults with cognitive impairment using in-context, semi-structured interviews and unobtrusive direct observation of patients, families, and healthcare workers. The investigators will employ participant observation and semi-structured interviews for each enrolled patient-family member dyad. For each dyad, the investigators will conduct two interviews, each lasting approximately 30-60 minutes. One interview will occur within 24 hours of admission ("entry interview") and one within 72 hours of discharge ("exit interview"). Both interviews will address how the participant (patient if able to contribute, and family member) perceive the family member in relation to the healthcare team and their experiences of involvement in care. Each dyadic patient/family interview will be conducted by the Principal Investigator or her delegate and digitally recorded, with the consent of participants, for subsequent transcription and analysis. In addition, three periods of direct observation will occur. Direct observations will focus on interactions between hospital staff, patients, and families, and what family members do during a patient's hospital stay. Observations will be recorded as field notes. Finally, the investigators will interview one to three healthcare workers (physicians, advanced practice providers, nurses) involved in the patient's care for each enrolled patient-family dyad. Healthcare worker interviews will take place either during the patient's hospitalization or within a week of the patient's discharge and may take place in person or remotely (phone or videoconference). Demographic and baseline data from the patient, family member, and healthcare workers that may affect family involvement will also be collected.

AIM 2: To understand hospital leadership perspectives on barriers to integration of family members into care for hospitalized older adult patients with cognitive impairment. For this aim, the investigators will conduct one-on-one interviews hospital leadership. After consent is obtained, study staff will conduct each interview using a semi-structured interview guide which queries topics on system-level facilitators and barriers to family involvement in the care of hospitalized older adults with cognitive impairment (e.g., visiting hour policies, rounding schedules). Aim 2 will also include an artifact analysis of policy documents related to visitation, care of cognitively impaired older adults, and family-centered care in the hospital.

Eligibility

AIM 1:

Inclusion criteria for patient participants:

  • Having a documented diagnosis of dementia or cognitive impairment
  • Slated for admission to the hospital or admitted to the hospital
  • Able to speak about the topics in the interview in English
  • Capable of providing consent OR legally authorized representative (LAR) consents to patient's participation in study
        Exclusion criteria for patient participants: Incapable of providing consent AND LAR unable
        to be reached or does not consent
        Inclusion criteria for "family" participants:
          -  Age 18 or older
          -  Able to speak about the topics in the interview in English
          -  Is accompanying the patient slated for admission to the hospital or admitted to the
             hospital when the patient is approached, is the person the patient identifies as being
             the family member most involved in their hospital care, or is the emergency contact
             person for the patient listed in the medical record
          -  Willing to participate
        Exclusion criteria for "family" participants:
          -  Incapable of providing informed consent
          -  Accompanying patient as a paid caregiver or aide
        Inclusion criteria for health care worker participants:
          -  Age >18
          -  Employed by Duke University Health System
          -  Physician, advanced practice provider (APP), or nurse on the care team of the patient
             with cognitive impairment
          -  Able to provide informed consent
          -  Willing to participate
        Exclusion criteria for health care worker participants: Other profession (non-physician,
        APP, or nurse) on care team of the patient
        AIM 2:
        Inclusion criteria: Hospital executives, department chairs, division chiefs, nurse
        managers, medical directors, and other health system leaders.
        Exclusion criteria: Does not have leadership role within the health system.

Study details

Dementia

NCT06374992

Duke University

28 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.